Erick Lucera
Director of Finance/CFO bei EDITAS MEDICINE, INC.
Vermögen: 1 Mio $ am 31.03.2024
Profil
Erick J.
Lucera currently works at Beyond Air, Inc., as Independent Director from 2017, Beyond Air Ltd., as Director from 2017, SAB Biotherapeutics, Inc., as Independent Director from 2023, and Editas Medicine, Inc., as Chief Financial Officer & Executive Vice President from 2023.
Mr. Lucera also formerly worked at Triathlon Fund Management LLC, as Chief Executive Officer from 2004 to 2007, Bone Biologics Corp., as Director from 2021 to 2024, Eaton Vance Management, as Vice President from 2008 to 2012, Independence Investments LLC, as Principal from 1995 to 2004, Nuwellis, Inc., as Vice President-Corporate Development in 2012, Triathlon Life Sciences Fund LP, as Portfolio Manager, Aratana Therapeutics, Inc., as Vice President-Corporate Development from 2012 to 2015, Valeritas Holdings, Inc., as Chief Financial Officer, Secretary & Executive VP, Pricewaterhouse & Co., as Principal from 1990 to 1993, AVEO Pharmaceuticals, Inc., as Chief Financial Officer from 2020 to 2023, and Viventia Bio, Inc., as Chief Financial Officer, Secretary & Treasurer from 2015 to 2016.
Mr. Lucera received his graduate degree in 1999 from Boston College, Masters Business Admin degree in 1995 from Indiana University, and undergraduate degree in 1990 from the University of Delaware.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
EDITAS MEDICINE, INC.
0,17% | 02.03.2024 | 139 166 ( 0,17% ) | 1 Mio $ | 31.03.2024 |
BEYOND AIR, INC.
0,01% | 20.03.2024 | 4 342 ( 0,01% ) | 7 555 $ | 31.03.2024 |
| 18.03.2024 | 0 ( -.--% ) | - $ | 31.03.2024 |
Aktive Positionen von Erick Lucera
| Unternehmen | Position | Beginn |
|---|---|---|
| BEYOND AIR, INC. | Director/Board Member | 10.08.2017 |
| SAB BIOTHERAPEUTICS, INC. | Director/Board Member | 03.04.2023 |
| EDITAS MEDICINE, INC. | Director of Finance/CFO | 17.05.2023 |
Beyond Air Ltd.
 Beyond Air Ltd. BiotechnologyHealth Technology Beyond Air, Ltd. is a clinical-stage medical device and biopharmaceutical company engaging in the development of nitric oxide generator and delivery system that uses nitric oxide generated from ambient air and delivers precise amounts of nitric oxide to the lungs for the potential treatment of respiratory and other diseases. The company was founded by Yossef Av-Gay, Amir Avniel, and David Greenberg in May 2011 and is headquartered in Rehovot, Israel. | Director/Board Member | 01.08.2017 |
Ehemalige bekannte Positionen von Erick Lucera
| Unternehmen | Position | Ende |
|---|---|---|
| BONE BIOLOGICS CORPORATION | Director/Board Member | 11.01.2024 |
| AVEO PHARMACEUTICALS, INC. | Director of Finance/CFO | 01.02.2023 |
| VALERITAS HOLDINGS, INC. | Director of Finance/CFO | 01.12.2019 |
Viventia Bio, Inc.
 Viventia Bio, Inc. BiotechnologyHealth Technology Viventia Bio, Inc. operates as a biologics oncology company, which focuses on designing, engineering, and developing targeted protein therapeutics. The company was founded by Leslie Lewis Dan in October 2012 and is headquartered in Winnipeg, Canada. | Director of Finance/CFO | 01.08.2016 |
| ARATANA THERAPEUTICS INC | Corporate Officer/Principal | 01.04.2015 |
Ausbildung von Erick Lucera
| Boston College | Graduate Degree |
| Indiana University | Masters Business Admin |
| University of Delaware | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 4 |
|---|---|
| NUWELLIS, INC. | Health Technology |
| EDITAS MEDICINE, INC. | Health Technology |
| BONE BIOLOGICS CORPORATION | Health Technology |
| BEYOND AIR, INC. | Health Technology |
| Private Unternehmen | 11 |
|---|---|
Eaton Vance Management
 Eaton Vance Management Investment ManagersFinance Eaton Vance Management (EVM) is a registered mutual fund manager headquartered in Boston, Massachusetts. The firm was founded in 1979 when Eaton & Howard merged with Vance, Sanders & Co. Prior to March 2021, they were a wholly-owned subsidiary of Eaton Vance Corp. Their direct owner is Morgan Stanley Domestic Holdings, Inc., ultimately held by Morgan Stanley (NYSE: MS). EVM provides investment advice to institutional clients, mutual funds, other pooled investment vehicles, and retail separately managed accounts. | Finance |
Independence Investments LLC
 Independence Investments LLC Investment ManagersFinance Founded in 1982, Independence Investment LLC is a wholly owned investment management subsidiary of John Hancock Financial Services, Inc. (NYSE: JHF) The firm is located in Boston. | Finance |
Triathlon Fund Management LLC
 Triathlon Fund Management LLC Investment ManagersFinance Triathlon Fund Management LLC is a hedge fund headquartered in Boston. | Finance |
Triathlon Life Sciences Fund LP
 Triathlon Life Sciences Fund LP Investment ManagersFinance Part of Triathlon Fund Management LLC, Triathlon Life Sciences Fund LP is a private equity fund. | Finance |
Aratana Therapeutics, Inc.
 Aratana Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Aratana Therapeutics, Inc. engages in the development and commercialization of pet therapeutics. Its portfolio includes NOCITA, ENTYCE, and GALLIPRANT. NOCITA (bupivacaine liposome injectable suspension) acts as a local post-operative analgesia for cranial cruciate ligament surgery in dogs, and as a peripheral nerve block to provide regional post-operative analgesia following onychectomy in cats. ENTYCE(capromorelin oral solution) is intended for appetite stimulation in dogs. GALLIPRANT (grapiprant tablets) is for the control of pain and inflammation associated with osteoarthritis in dogs. The company was founded by Linda Rhodes and Steven St. Peter on December 1, 2010 and is headquartered in Leawood, KS. | Health Technology |
Valeritas Holdings, Inc.
 Valeritas Holdings, Inc. Medical SpecialtiesHealth Technology Valeritas Holdings, Inc. develops and commercializes insulin delivery devices. The company was founded by Leisa Swanson and Robert R. Gonnelli on August 2, 2006 and is headquartered in Bridgewater, NJ. | Health Technology |
| Pricewaterhouse & Co. | Commercial Services |
AVEO Pharmaceuticals, Inc.
 AVEO Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology AVEO Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the advancement of therapeutics for oncology, and other areas of unmet medical need. Its product candidates include Tivozanib, Ficlatuzmab, AV-203, AV-380 and AV-353. The company was founded by Ronald A. DePinho, Lynda Chin, and Kenneth E. Weg on October 19, 2001 and is headquartered in Cambridge, MA. | Health Technology |
Beyond Air Ltd.
Beyond Air Ltd. BiotechnologyHealth Technology Beyond Air, Ltd. is a clinical-stage medical device and biopharmaceutical company engaging in the development of nitric oxide generator and delivery system that uses nitric oxide generated from ambient air and delivers precise amounts of nitric oxide to the lungs for the potential treatment of respiratory and other diseases. The company was founded by Yossef Av-Gay, Amir Avniel, and David Greenberg in May 2011 and is headquartered in Rehovot, Israel. | Health Technology |
Viventia Bio, Inc.
Viventia Bio, Inc. BiotechnologyHealth Technology Viventia Bio, Inc. operates as a biologics oncology company, which focuses on designing, engineering, and developing targeted protein therapeutics. The company was founded by Leslie Lewis Dan in October 2012 and is headquartered in Winnipeg, Canada. | Health Technology |
| SAB Biotherapeutics, Inc. |
